Serum calprotectin is a marker of disease activity in Giant cell arteritis-Reference-Cited by-同舟云学术

Serum calprotectin is a marker of disease activity in Giant cell arteritis

Published:2023-12 Issue:12 Volume:22 Page:103469
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Saut Antoine,Paclet Marie-Hélène,Trocmé Candice,Toussaint Bertrand,Bocquet Alexis,Bouillet Laurence,Baillet Athan

Funder

Société Française d'Hématologie

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference13 articles.

1. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis: phagocytes in giant cell arteritis;Foell;J Pathol,2004

2. Distinct patterns of gene expression in temporal artery biopsies associated with pathogenesis of giant cell arteritis;Hajj-Ali;Arthritis Rheum,2006

3. Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis;van Sleen;Rheumatology,2019

4. Serum amyloid a as a marker of disease activity in Giant cell arteritis;Dartevel;Autoimmun Rev,2020

5. 2018 update of the EULAR recommendations for the management of large vessel vasculitis;Hellmich;Ann Rheum Dis,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive biomarkers of response to tocilizumab in giant cell arteritis (GCA): correlations with imaging activity;Immunologic Research;2024-08-30

2. Serum Calprotectin in the Evaluation of Gastrointestinal Diseases: An Ace up Your Sleeve?;Medicina;2024-05-05

3. New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis;RMD Open;2024-02